Related Experiment Video
Updated: Jul 10, 2025

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and
Oyahida Khatun1,2, Mansi Sharma1,2, Rohan Narayan1,2
1Emerging Viral Pathogens Laboratory, Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India.
Abstract:
Evasion and antagonism of host cellular immunity upon SARS-CoV-2 infection provide replication advantage to the virus and contribute to COVID-19 pathogenesis. We explored the ability of different SARS-CoV-2 proteins to antagonize the host's innate immune system and found that the ORF6 protein mitigated type-I Interferon (IFN) induction and downstream IFN signaling. Our findings also corroborated previous reports that ORF6 blocks the nuclear import of IRF3 and STAT1 to inhibit IFN induction and signaling. Here we show that ORF6 directly interacts with RIG-I and blocks downstream type-I IFN induction and signaling by reducing the levels of K63-linked ubiquitinated RIG-I. This involves ORF6-mediated targeting of E3 ligase TRIM25 for proteasomal degradation, which was also observed during SARS-CoV-2 infection. The type-I IFN antagonistic activity of ORF6 was mapped to its C-terminal cytoplasmic tail, specifically to amino acid residues 52-61. Overall, we provide new insights into how SARS-CoV-2 inhibits type-I IFN induction and signaling through distinct actions of the viral ORF6 protein.
Insights
The SARS-CoV-2 ORF6 protein inhibits the host
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- SARS-CoV-2 evades host immunity, aiding viral replication and COVID-19.
- Type-I Interferons (IFNs) are crucial for innate immune defense against viral infections.
Purpose of the Study:
- To investigate the role of SARS-CoV-2 proteins in antagonizing host innate immunity.
- To elucidate the specific mechanism by which ORF6 protein inhibits type-I IFN induction and signaling.
Main Methods:
- Exploration of SARS-CoV-2 protein interactions with host immune components.
- Analysis of Interferon Regulatory Factor 3 (IRF3) and Signal Transducer and Activator of Transcription 1 (STAT1) nuclear import.
- Investigation of ORF6 interaction with RIG-I and its ubiquitination status.
- Mapping of ORF6's type-I IFN antagonistic activity to its C-terminal tail.
Main Results:
- SARS-CoV-2 ORF6 protein mitigates type-I Interferon (IFN) induction and signaling.
- ORF6 blocks IRF3 and STAT1 nuclear import, inhibiting IFN pathways.
- ORF6 directly interacts with RIG-I, reducing K63-linked ubiquitination and downstream IFN induction.
- ORF6 targets E3 ligase TRIM25 for proteasomal degradation, a process observed during SARS-CoV-2 infection.
- The C-terminal cytoplasmic tail of ORF6 (residues 52-61) is responsible for type-I IFN antagonism.
Conclusions:
- SARS-CoV-2 ORF6 protein is a key viral factor that antagonizes the host's type-I IFN response.
- ORF6 employs multiple strategies, including RIG-I ubiquitination disruption and TRIM25 degradation, to inhibit IFN induction and signaling.
- Understanding ORF6's mechanism provides insights into SARS-CoV-2 pathogenesis and potential therapeutic targets.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Regulation of the Unfolded Protein Response
Experimental RNAi
The Unfolded Protein Response
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Leaky Scanning

